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Abstract
Background: Elderly patients are at particular risk for bacteremia and sepsis. Atypical presentation may complicate
the diagnosis. We studied patients with bacteremia, in order to assess possible age-related effects on the clinical
presentation and course of severe infections.
Methods: We reviewed the records of 680 patients hospitalized between 1994 and 2004. All patients were
diagnosed with bacteremia, 450 caused by Escherichia coli and 230 by Streptococcus pneumoniae. Descriptive
analyses were performed for three age groups (< 65 years, 65–84 years, ≥ 85 years). In multivariate analyses age was
dichotomized (< 65, ≥ 65 years). Symptoms were categorized into atypical or typical. Prognostic sensitivity of CRP
and SIRS in identifying early organ failure was studied at different cut-off values. Outcome variables were organ
failure within one day after admission and in-hospital mortality.
Results: The higher age-groups more often presented atypical symptoms (p <0.001), decline in general health
(p=0.029), and higher in-hospital mortality (p<0.001). The prognostic sensitivity of CRP did not differ between age
groups, but in those ≥ 85 years the prognostic sensitivity of two SIRS criteria was lower than that of three criteria.
Classical symptoms were protective for early organ failure (OR 0.67, 95% CI 0.45-0.99), and risk factors included;
age ≥ 65 years (OR 1.65, 95% CI 1.09-2.49), comorbid illnesses (OR 1.19, 95% CI 1.02-1.40 per diagnosis), decline in
general health (OR 2.28, 95% CI 1.58-3.27), tachycardia (OR 1.50, 95% CI 1.02-2.20), tachypnea (OR 3.86, 95% CI 2.64-5.66),
and leukopenia (OR 4.16, 95% CI 1.59-10.91). Fever was protective for in-hospital mortality (OR 0.46, 95% CI 0.24-0.89),
and risk factors included; age ≥ 65 years (OR 15.02, 95% CI 3.68-61.29), ≥ 1 comorbid illness (OR 2.61, 95% CI 1.11-6.14),
bacteremia caused by S. pneumoniae (OR 2.79, 95% CI 1.43-5.46), leukopenia (OR 4.62, 95% CI 1.88-11.37), and number
of early failing organs (OR 3.06, 95% CI 2.20-4.27 per failing organ).
Conclusions: Elderly patients with bacteremia more often present with atypical symptoms and reduced general
health. The SIRS-criteria have poorer sensitivity for identifying organ failure in these patients. Advanced age,
comorbidity, decline in general health, pneumococcal infection, and absence of classical symptoms are markers of a
poor prognosis.
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Background
The incidence of sepsis in humans has been shown to
increase with age [1-3]. Elderly patients are at particular
risk for bacteremia and sepsis owing to multiple factors
such as comorbid illnesses, immunosenescence, malnutri-
tion, instrumentation and institutionalization [4]. Previous
studies have identified age as an independent risk factor
for death due to sepsis [3,5,6] and for severe bloodstream
infections [7-12], although conflicting results are also
reported [13].
The clinical presentation of sepsis is often atypical in
elderly patients, complicating and potentially delaying
diagnosis [4]. A decline in general health and unspecific
functional deterioration, such as reduced ability to perform
daily tasks, may be the only symptoms of severe illness, in-
cluding sepsis [14]. Possible effects of age-related biological
changes upon the clinical course or prognosis of sepsis are
not well described. In addition, it is not known whether
atypical presentation is predictive of severe sepsis or
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death when established criteria for sepsis and organ
failure are used.
To address the special challenges regarding clinical
evaluations of elderly patients with severe infection we
studied 1) the clinical presentation and severity related
to age, 2) age linked differences in prognostic sensitivity
of C-reactive protein (CRP) and systemic inflammatory
response syndrome (SIRS) for early organ failure, and
3) whether age and age-related clinical presentation are
additional risk factors for early organ failure and death, in
a mixed group of patients with community-acquired
bacteremia caused by E. coli or S. pneumoniae.
Methods
Patients and setting
This study was conducted at Aker University Hospital in
Oslo, Norway, between 1994 and 2004. During the study
period, the hospital had 350 beds and served a population
of 500,000 people for urology and abdominal vascular
surgery, and 180,000 people for internal medicine, general
surgery and psychiatry.
Medical records for all adult (≥ 16 years) patients
admitted during the study period with culture-verified
bacteremia due to E. coli or S. pneumoniae infection
were retrieved from the hospital’s bacteriology laboratory
database. Patients who had more than one episode of
bacteremia during the study period were registered only
once in the study. As we wanted to study community-
acquired infections, we included only patients who had
blood cultures drawn on the day of or day after hospital
admission. Only patients with medical records available
were included in the study.
Clinical data
The following clinical data on comorbidities, risk factors
for infection, diagnoses, signs and symptoms were extracted
from medical records for all patients included in the study.
Comorbid illnesses specified in the medical records
were extracted and categorized using a predefined list.
Malignant disease was registered in cases of cancer or
hematological malignancy. Alcoholism was registered when
accompanied by organ involvement or social decompen-
sation. Chronic renal failure was registered if repeated
creatinine values > 500 μmol/L in preceding admissions,
differentiated as severe if combined with dialysis or
medication specific for renal failure, and as moderate
chronic if neither dialysis nor medication specific for
renal failure was recorded. Heart failure and cardiomy-
opathy were both registered as heart failure.
Risk factors for infection included having an indwelling
urinary catheter, surgical procedure at site of infection
within the two weeks prior to admission, obstruction of the
gastrointestinal or urinary tracts, and chronic inflammation.
Medication with implicit risk for infection included use of
corticosteroids ≥ a dose equivalent to 10 mg prednisolone
per day, chemotherapy in the two weeks before admission
or other immunosuppressive medication on a daily basis.
Tentative diagnoses by the admitting physicians were
categorized into infection, non-specific diagnoses (including
delirium and acute deterioration in the ability to perform
daily tasks), organ-specific diagnoses not indicating an
infection (i.e. myocardial infarction, acute abdominal
pain, acute asthma), and missing/others.
Symptoms indicative of infection preceding admission
were dichotomized into “classical symptoms” and “atypical
symptoms”. “Classical symptoms” included fever/chills,
localized pain, nausea/vomiting, diarrhea, cough, dyspnea,
expectoration, urinary urgency, painful voiding, hematuria,
skin rash, coma, and seizures, whereas “atypical symptoms”
included malaise, falls, dizziness, syncope, unsteadiness,
immobility, acute urinary or fecal incontinence, paresis,
speaking difficulties, and confusion.
Signs of infection in the emergency department (ED)
included decline in general health if recorded. Findings
during the physical examination indicative of localized
pathology were recorded, and markers of systemic in-
flammatory response syndrome (SIRS) were registered
according to international standards [15]. The SIRS
criteria include body temperature more than 38.0°C or
less than 36.0°C; heart rate more than 90 beats per minute;
tachypnea manifested by a respiratory rate more than 20
breaths per minute or as a partial pressure of CO2 below
4.30 kPa; and a white blood cell count greater than
12,000/mm3 or below 4,000/mm3. The SIRS criteria
were considered not met if data were not recorded. We
used two alternative cut points for SIRS, ≥ 2 criteria met
(SIRS-2) and ≥ 3 criteria met (SIRS-3). Cut points from
the Simplified Acute Physiology Score (SAPS) [16] were
used to define hypothermia (body temperature less than
36.0°C), fever (body temperature ≥ 38.5°C), leukocytosis
(leukocyte counts above 15,000/mm3), and leukopenia
(leukocyte counts below 3,000/mm3). C-reactive protein
(CRP) values from blood samples drawn on the day of
admission were categorized at 80 mg/L, which is applicable
for predicting sepsis in patients with SIRS [17], and
200 mg/L, which is the suggested level for differentiating
infection from other causes of shock [18]. We included
new-onset atrial fibrillation as a marker of severe infection,
as described previously [19].
Presumed primary site of infection was identified by
one of the clinically trained authors (ALW) based on the
medical history, symptoms, physical examination, blood
tests, X-rays, specimen cultures from other body sites than
blood, biopsies from surgical procedures, and autopsies.
The sites of infection were categorized into urinary tract,
lower respiratory tract, other (i.e. gastrointestinal tract, liver,
pancreas and biliary tract, central nervous system), or
inconclusive.
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Criteria for organ failure
Criteria for organ failure within one day after admission
are presented in the Additional file 1. Whenever possible,
criteria were defined according to the Sequential Organ
Failure Assessment (SOFA) score system (cut point 2 or 3)
[20]. Indicators for organ dysfunction, defined in the diag-
nostic criteria for sepsis in 2001 [21] and for severe sepsis
and septic shock in 1992 [15], were also used. Criteria
for acute renal failure were adjusted to the modified risk,
injury, failure, loss and end-stage kidney (RIFLE) criteria
[22], and on clinical presentation. Since the central nervous
system is included in organ failure scoring systems for use
in sepsis [23], we included impaired consciousness as an
indicator of organ failure. However, signs of delirium were
not included, because data on this state were not routinely
collected upon admission. Data on liver and hematological
markers as well as markers of peripheral perfusion such as
serum lactate were not systematically registered in patient
records, and were therefore excluded.
Date of death
Date of death during hospitalization was extracted from
patient records. For analytical purposes, mortality was
classified into early hospital mortality (within ≤ 3 days of
admission), and in-hospital death within 14 days of
admission. Prior to the data extraction process survival
after discharge from hospital had been confirmed
through the National Population Register by the medical
record staff. If death had occurred after the index stay,
they had put the date onto the records.
Statistical methods
In order to study any systematic differences in clinical
presentation related to the oldest patients, descriptive
analyses were performed for three age groups (< 65 years,
65–84 years and ≥ 85 years). In the multivariate analyses,
however, age was dichotomized (< 65 and ≥ 65) based on
preliminary analyses. Categorical variables were presented
as absolute numbers and percentages and compared using
Chi-squared tests. Normally distributed numerical variables
were compared using one-way ANOVA, and non-normal
variables using Kruskal-Wallis tests and Mann–Whitney
tests. The number of “classical” symptoms was dichot-
omized at three symptoms, “atypical” symptoms were
dichotomized at one symptom.
Non-parametric correlation analysis (Spearman rho) was
performed to study the relationship between CRP value at
admission and the number of failing organs within one day
of admission. The associations between organ failure and
different cut-points of CRP and different number of SIRS
criteria were explored using Chi-squared tests.
In order to identify factors recorded upon admission
to the ED independently associated with either early organ
failure or in-hospital death (truncated at 14 days after
admission to hospital), variables significantly associated
with these outcomes (p < 0.05) in bivariate analyses were
entered into binary logistic regression models. Ordinal
factors not linearly associated with either of the two
outcomes were dichotomized. For variable selection, we
used backward stepwise removal of variables based on
likelihood-ratio judgments. Model summary given in
Nagelkerke R square and model of fit given by the Hosmer
and Lemeshow test were applied. We also tested for any
interactions between the dichotomized age variable and
the other factors in the full main effects models. To obtain
the logit of the two outcomes when interactions were ac-
tive, the macro Modprobe developed and adjusted to SPSS
by Hayes and Matthes was applied [24]. However, since the
statistical power of interaction analyses is generally low, the
effects of interacting variables on outcomes are presented
only as directions rather than graphically or by numbers.
One-year survival by number of early failing organs,
bacterial species, and age were analyzed using Kaplan
Meier survival analysis, applying the log-rank test. A
Kaplan Meier plot was used to present the results
graphically. All analyses were performed with SPSS 17.0
software (SPSS, Chicago, IL).
Ethical considerations
The study was approved by the South-East Norway
Regional Committee for Ethics in Medical Research.
The Norwegian Data Inspectorate gave permission to carry
out the study without the patient consent. Dispensation of
professional confidentiality was given by the Norwegian
Directorate of Health.
Results
Between 1994 and 2004, 1150 patients had a blood culture
positive for either E. coli or S. pneumoniae. Of these, 759
had the positive blood culture drawn on the day of admis-
sion or the following day. For 79 patients the clinical data
was either unavailable or inadequate for analyses. In total,
a cohort of 680 patients was eligible for the study.
Table 1 presents basic characteristics, comorbid illnesses
and clinical presentation by age group. The two oldest age
groups had more comorbid illnesses and were more often
admitted with non-specific tentative diagnoses than the
youngest group. The two oldest age groups also differed
from the youngest group by less frequently having “clas-
sical” symptoms and more frequently having “atypical”
symptoms. In addition, the two oldest age groups presented
more often with decline in general health, new-onset atrial
fibrillation and reduced consciousness than the youngest
group. Table 2 describes severity of infection by age group.
The mean number of failing organs within one day after
admission was significantly higher in the middle group
than in the youngest age group. For the two oldest age
groups, the site of infection was more difficult to
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Table 1 Descriptive data and clinical presentation by 3 age groups
Total material
(680 patients)
Age groups (% within age group)
< 65 years 65-84 years ≥ 85 years Overall
p-value(228 patients) (334 patients) (118 patients)
Age in years; median (IQR) 75 (57.5 - 82) 50.5 (38–58) 78 (73–81) 88 (86–91)
Gender; male 289 (42.5%) 93 (40.8%) 160 (47.9%) 36 (30.5%) 0.004
Bacteraemia caused by E. coli 450 (66.2%) 131 (57.5%) 240 (71.9%) 79 (66.9%) 0.002
Bacteremia caused by S. pneumoniae 230 (33.8%) 97 (42.5%) 94 (28.1%)* 39 (33.1%)
Comorbidity
Number of comorbid conditions1; median (IQR) 1 (0–2) 0 (0–1) 1 (0–2)* 1 (1–2)* < 0.001
Aftrial fibrrillation (chronic or paroxystic) 75 (11.2%) 0 47 (14.2)* 28 (24.3)* < 0.001
Ischemic heart disease 145 (21.6%) 13 (5.8%) 91 (27.5%)* 41 (35.7%)* < 0.001
Congestive heart failure 91 (13.5%) 6 (2.7%) 55 (16.6%)* 30 (26.1%)* < 0.001
Hypertension 151 (22.5%) 25 (11.1%) 91 (27.5%)* 35 (30.4%)* < 0.001
Cerebrovascular disorder 93 (13.8%) 11 (4.9%) 59 (17.8%)* 23 (20.0%)* < 0.001
Chronic obstructive lung disease 71 (10.6%) 15 (6.6%) 50 (15.1%)* 6 (5.2%) 0.001
Alcohol abuse 46 (6.8%) 24 (10.6%) 21 (6.3%) 1 (0.9%)* 0.003
Malignant disease (solid cancer, leukemia or lymphoma) 45 (6.7%) 16 (7.1%) 24 (7.3%) 5 (4.3%) 0.540
Chronic renal failure 21 (3.1%) 6 (2.7%) 12 (3.6%) 3 (2.6%) 0.763
Diabetes mellitus 82 (12.2%) 20 (8.8%) 49 (14.8%)* 13 (11.3%) 0.103
Tentative diagnosis by admitting physician:
Infection 331 (48.7%) 132 (57.9%) 143 (42.8%)* 56 (47.5%) 0.002
Non-specific2 89 (13.1%) 7 (3.1%) 59 (17.7%)* 23 (19.5%)* < 0.001
Organ focused 158 (23.2) 56 (24.6%) 78 (23.4%) 24 (20.3%) 0.676
Symptoms on infection
Total number of reported symptoms; median (IQR) 3 (2–4) 3 (2–4) 3 (2–4) 3 (2–3) 0.351
“Classical symptoms”3 ≥ 3 253 (37.4%) 110 (48.7%) 108 (32.5%)* 35 (29.7%)* < 0.001
Zero ”classical symptoms” 57 (8.4%) 7 (3.1%) 36 (10.8%)* 14 (11.9%)* 0.002
“Atypical symptoms”4 ≥ 1 337 (49.6%) 82 (36.0%) 180 (53.9%)* 75 (63.6%)* < 0.001
Signs of infection at admission
Decline in general health 289 (42.6%) 81 (35.5%) 152 (45.6%)* 56 (47.5%)* 0.029
Leukocytosis (≥ 15000/μl) 280 (41.2%) 98 (43.0%) 129 (38.6%) 53 (45.3%) 0.363
Leukopenia (< 3000/μl) 37 (5.4%) 8 (3.5%) 24 (7.2%) 5 (4.3%) 0.140
C-reactive protein (CRP)
CRP median (IQR); mg/L 191 (83–311) 222 (92 -351) 179 (72-266)* 180 (94-317) 0.022
CRP ≥ 80 mg/L 514 (75.6%) 175 (76.8%) 245 (73.4%) 94 (79.7%) 0.344
CRP ≥ 200 mg/L 324 (47.6%) 123 (53.9%) 147 (44.0%) 54 (45.8%) 0.062
Fever (≥ 38.5°C) 438 (65.8%) 154 (69.1%) 208 (64.0%) 76 (64.4%) 0.445
Hypothermia (< 36°C) 10 (1.5%) 7 (3.1%) 1 (0.3%)* 2 (1.7%) 0.027
Median number of SIRS criteria (IQR) 3 (2–3) 3 (2–3) 2 (2–3) 2 (2–3) 0.099
No. of patients with SIRS ≥ 3 343 (50.4%) 127 (55.7%) 160 (47.9%) 56 (47.5%) 0.149
No. of patients with SIRS ≥ 2 563 (82.8%) 198 (86.8%) 270 (80.8%) 95 (80.5%) 0.139
New-onset atrial fibrillation 104 (15.5%) 11 (4.9%) 72 (21.8%)* 21 (18.3%)* < 0.001
1 Comorbid conditions: Malignant disease, alcoholism, diabetes mellitus, chronic renal failure, heart failure. 2 Non-specific tentative diagnoses: acute deterioration
of performing daily tasks, reduced general condition, confusion, dizziness, falls, fainting, question of cerebral infarction. 3 “Typical symptoms”: fever/chills, localized
pain, nausea/vomiting, diarrhoea, cough, dyspnoea, expectoration, signs of urinary tract infection (UTI) such as urgency, pyuria, haematuria; skin rash, coma,
seizures. 4 “Atypical symptoms”: Malaise, fall/dizziness/syncope/unsteadiness, immobility, acute incontinence of urine or faeces, paresis, speaking difficulties,
confusion. *Significantly different from the age group < 65, which was treated as reference group.
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determine than the youngest group. Furthermore, the
two oldest age groups died earlier after admission and
had higher in-hospital and one-year mortality than the
youngest group.
The CRP values at admission were significantly correlated
to the number of failing organs within one day after
admission (rs = 0.13, p = 0.001). Figure 1 shows the
prognostic sensitivity with 95% confidence intervals of
initial CRP value and of SIRS at different cut-off values in
predicting ≥1 organ failure by age group. The prognostic
sensitivity of a CRP value above 200 mg/L was lower in
the middle age group than in the youngest group, whereas
no age-associated differences were seen at cut-off value
80 mg/L. The prognostic sensitivity of SIRS-2 was lower
than that of SIRS-3 for the two oldest age groups, but not
for the youngest age group.
In Table 3, predictors for early organ failure available
at admission are presented. Sufficient data on organ failure
were available for 632 patients. As can be seen, age over 65
years, number of comorbid illnesses, more than three
“classical” symptoms present, decline in general health,
tachypnea and/or hyperventilation, and leukopenia
remained as independent and statistically significant
predictors in the multivariate model. The model con-
tributed moderately to the prediction of having one or
more failing organs (Nagelkerke R2 = 0.289), and fitted
Table 2 Site and severity of infection by 3 age groups
Total material
(680 patients)
Age groups (% within age group)
< 65 years 65-84 years ≥ 85 years Overall
p-value(228 patients) (334 patients) (118 patients)
Acute organ failure within 1 day after admission
No. of acute organ failures; mean (95% CI)) 0.69 (0.62 – 0.76) 0.53 (0.41 – 0.64) 0.80 (0.70 – 0.90)* 0.70 (0.53-0.88) 0.003
Presence of ≥ 1 organ failure 290 (45.9%) 75 (35.2%) 165 (53.1%)* 50 (46.4%) < 0.001
Type of acute organ failure
Cardiovascular failure 80 (11.8%) 21 (9.3%) 50 (15.0%)* 9 (7.6%) 0.035
Respiratory failure 192 (28.2%) 54 (23.7%) 102 (30.5%) 36 (30.5%) 0.173
Acute renal failure 30 (4.5%) 6 (2.7%) 20 (6.1%) 4 (3.4%) 0.144
Coagulation failure 54 (8.4%) 14 (6.5%) 32 (10.1%) 8 (7.3%) 0.299
(platelets < 100x103/mm3)
Reduced consciousness 99 (14.6%) 19 (8.3%) 55 (16.5%)* 25 (21.4%)* 0.002
Sepsis-diagnosis at discharge
Sepsis as main or side diagnosis (ICD-9 or ICD-10) 313 (46.0%) 86 (37.7%) 171 (51.2%)* 56 (47.5%) 0.007
Site of infection
Urinary tract 255 (37.5%) 84 (36.8%) 132 (39.5%) 39 (33.1%) 0.445
Respiratory system 228 (33.5%) 94 (41.2%) 95 (28.4%)* 39 (33.1%) 0.007
Other sites1 107 (15.7%) 32 (14.0%) 61 (18.3%) 14 (11.9%) 0.179
Inconclusive 90 (13.2) 18 (7.9%) 46 (13.8%)* 26 (22.0%)* 0.001
Hospital stay
Department responsible at admission:
Surgical department (urology included) 138 (20.3%) 60 (26.3%) 61 (18.3%) 17 (14.4%) 0.006
Medical department 525 (77.2%) 161 (70.6%) 268 (80.2%) 96 (81.4%)
Other departments; and missing 17 (2.5%) 7 (3.1%) 5 (1.5%) 5 (4.2%)
Transferred to an ICU within 1 day after admission 153 (22.5%) 55 (24.1%) 82 (24.6%) 16 (13.6%)* 0.038
Length of stay in days; median (IQR) 8 (5–14) 7 (5–11) 9 (6–16)* 9 (5–15) 0.008
In-hospital mortality
Total in-hospital mortality 92 (13.5%) 12 (5.3%) 62 (18.6%)* 18 (15.3%)* <0.001
Day of in-hospital death; median (IQR) 5 (1–12) 16.5 (2.25 - 22.75) 6 (1–11.25) 2 (0.75 - 7) 0.065
Early in-hospital mortality (within 3 days after admission) 39 (5.7%) 4 (1.8%) 23 (6.9%)* 12 (10.2%)* 0.003
In-hospital mortality within 14 days after admission 72 (10.6%) 6 (2.6%) 51 (15.3%)* 15 (12.7%)* <0.001
One-year mortality 168 (24.7%) 30 (13.2%) 101 (30.3%)* 37 (31.4%)* <0.001
1 Gastrointestinal tract, liver, pancreas and biliary tract. * Significantly different from the age group < 65, which was treated as reference group.
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the data well (χ2 = 9.42, p = 0.30). Advanced age sig-
nificantly reduced the effect of tachypnea and/or
hyperventilation and the number of comorbid illnesses
on the risk for early organ failure.
Table 4 shows risk factors for in-hospital death within
14 days after admission. Age over 65 years, comorbidity,
bacteraemia with pneumococci (rather than E. coli),
leukopenia and number of failing organs within one
day after admission all remained as independent risk
factors for death, whereas having fever was protective.
The model contributed moderately to the prediction of
hospital mortality (Nagelkerke R2 = 0.428), and fitted
the data well (χ2 = 3.2, p = 0.92). Advanced age signifi-
cantly increased the effect of type of bacterium on
hospital mortality. Type of tentative diagnoses before
admission was not associated with mortality, whereas
having “atypical symptoms” was significant only in bivariate
analysis.
Figure 2 displays Kaplan Meier plots of one-year survival
curves by age group, number of failing organs and microbial
agent. There were significant differences in one-year survival
for age and number of failing organs (p < 0.001 for both),
but not for type of bacteria (p = 0.75).
Discussion
In this material, comprising nearly 700 patients with
bacteraemia caused by E. coli or S. pneumoniae, several
results indicate that age affects the clinical presentation,
diagnostic markers, and outcome of severe infection.
Elderly patients more often presented with “atypical”
symptoms like confusion, falls, malaise, incontinence
and immobility, whereas “classical” symptoms of infection
were more common among younger patients. The ED
doctor’s impression of decline in general health was also a
more frequent sign among the older patients. This reflects
the general perception in geriatric care [25], but has, to
Figure 1 Sensitivity of inflammatory markers for identifying ≥ 1 organ failure in bacteremia. Prognostic sensitivity of a) C-reactive protein
(CRP) and b) Systemic Inflammatory Response Syndrome (SIRS). CI = confidence interval.
Wester et al. BMC Infectious Diseases 2013, 13:346 Page 6 of 12
http://www.biomedcentral.com/1471-2334/13/346
our knowledge, not previously been confirmed in a large
cohort of bacteremic patients. Older patients die earlier
during hospitalization than younger patients [3], and are
more rarely transferred to an intensive care unit (ICU)
[13], both also found in our study. We speculate whether
advanced age to some extent reduces the chances of
patients receiving proper clinical monitoring and timely
antibiotic treatment. In contrast, in our results there was
no association between age and the degree of missing data
for bilirubin, arterial lactate and international standardized
ratio (results not shown), indicating that the adequacy of
monitoring was the same, irrespective of age.
Despite the efforts to broaden the understanding of
sepsis diagnosis beyond SIRS, this entity is still used as
rule in criteria for transfer to ICU and for aggressive
treatment. Elderly patients’ subtle presentation of infec-
tion makes the sensitivity of SIRS a matter of concern.
Studies of the prognostic value of SIRS in sepsis are
scarce due to the fact that SIRS itself is generally part of
the inclusion criteria. One study of ICU-patients with
bacteremia caused by Pseudomonas aeruginosa and
Enterococcus found no differences in SIRS between elderly
and younger patients [26]. In our material, the sensitivity
for organ failure of three SIRS criteria was lower than
that of two criteria in the elderly, whereas the confi-
dence intervals overlapped in the younger patients. If
absence of SIRS is used as an exclusion criterion for
tight observation and aggressive treatment, a prognostic
sensitivity of about 60% is hardly satisfactory, and this
finding is clearly clinically relevant.
The usefulness of CRP in sepsis diagnosis has been
questioned [27]. A recent meta-analysis on a mixed group
of ICU patients found that early CRP did not predict out-
come, whereas CRP at Day 2 following admission did [28].
Another study recently found that CRP is a useful marker
of sepsis resolution [29]. In our study, CRP at cut-off value
80 m mg/L was not associated to in-hospital mortality
within 14 days after admission, whereas CRP at cut-off
value 200 mg/L was, but only in the univariate analysis.
Interestingly, we found that the sensitivity of a high CRP-
level in the diagnosis of organ failure in bacteraemia is
lower in elderly patients than in younger patients.
Age was clearly associated with both early organ fail-
ure and in-hospital mortality, reflecting the findings of
other studies [3,5,6]. It is possible that these findings
could have been confounded by age-associated clinical
Table 3 Information available at admission predictive for ≥ 1 organ failure within one day
Patients without organ
failure (342 patients;
% within this group)
Patients with organ
failure (290 patients;
% within this group)
Bivariate
analyses
OR (95% CI)
Multivariate analysis;
full main effects’
model* OR (95% CI)
Age ≥ 65 years 204 (59.6) 215 (74.1) 1.94 (1.38-2.73) 1.65 (1.09 - 2.49)
Male gender 137 (40.1) 135 (46.6) 1.30 (0.95 – 1.79)
No. of comorbid illnesses - - 1.41 (1.23-1.61) 1.19 (1.02 - 1.40)
Corticosteroid on a daily basis1 8 (2.4) 23 (8.0) 3.55 (1.56 – 8.05) 2.75 (1.10 - 6.89)
Cytostatic treatment within last 14 days 1 (0.3) 6 (2.1) 7.10 (0.85 - 59.34)
Immunosuppressive treatment 1 (0.3) 5 (1.7) 5.90 (0.69 - 50.77)
Number of symptoms ≥ 5 35 (10.2) 41 (14.2) 1.45 (0.90 – 2.35)
“Classical symptoms”2 ≥ 3 141 (41.3) 97 (33.7) 0.72 (0.52 - 0.99) 0.67 (0.45 - 0.99)
“Atypical symptoms”3 ≥ 1 151 (44.2) 169 (58.3) 1.77 (1.29 - 2.42)
Decline in general health
(as described in the emergency department)
112 (32.8) 166 (57.2) 2.74 (1.98 - 3.79) 2.28 (1.58 - 3.27)
Heart rate > 90 beats per minute 197 (58.5) 203 (70.7) 1.72 (1.23 - 2.40) 1.50 (1.02 - 2.20)
Fever (≥ 38.5°C) 229 (68.4) 178 (62.2) 0.76 (0.55 - 1.06)
Hypothermia (< 36°C) 4 (1.2) 6 (2.1) 1.77 (0.50 - 6.35)
Tachypnoe and/or hyperventilation 78 (22.8) 167 (57.6) 4.60 (3.26 - 6.48) 3.86 (2.64 - 5.66)
Leukocytosis (≥ 15000/μl) 145 (42.4) 118 (40.7) 0.93 (0.68 - 1.28)
Leukopenia (< 3000/μl) 6 (1.8) 31 (10.7) 6.70 (2.76 - 16.31) 4.16 (1.59 - 10.91)
CRP ≥ 80 mg/L 253 (74.0) 233 (80.3) 1.44 (0.99 - 2.10)
CRP ≥ 200 mg/L 157 (45.9) 153 (52.8) 1.32 (0.96 -1.80)
New-onset atrial fibrillation 35 (10.4) 64 (22.1) 2.45 (1.57 - 3.82)
OR= odds ratio, CI = confidence interval. 1Equivalent to prednisolone ≥ 10 mg per day, 2“Classical symptoms”: fever/chills, localized pain, nausea/vomiting, diarrhea,
cough, dyspnea, expectoration, urgency, painful voiding, hematuria, skin rash and coma/seizures, 3“atypical symptoms”: Malaise, falls, dizziness, syncope, unsteadiness,
immobility, acute incontinence of urine or feces, paresis/speaking difficulties, acute confusional state. *Analyses of interactions indicated that high age significantly
reduced the effect of tachypnea and/or hyperventilation and the effect of number of comorbid illnesses on early organ failure (results not shown).
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Table 4 Predictive factors for in-hospital death within 14 days after admission
Alive at 14 days
(608 patients;
% within this group)
Patients that died within
14 days (72 patients;
% within this group)
Bivariate
analyses
OR (95% CI)
Multivariate analysis;
full main effects
model* OR (95% CI)
Age ≥ 65 years 386 (63.5) 66 (91.7) 6.33 (2.70 - 14.83) 15.02 (3.68 - 61.29)
Male gender 246 (40.5) 43 (59.7) 2.18 (1.33 - 3.59) 1.93 (1.002 - 3.70)
S. pneumoniae 196 (32.2) 34 (47.2) 1.88 (1.15 - 3.08) 2.79 (1.43 - 5.46)
Comorbid illnesses ≥ 1 355 (58.1) 59 (81.9) 3.27 (1.76 – 6.09) 2.61 (1.11 - 6.14)
Immunmodulating and other medication
Warfarin 51 (8.5) 5 (7.0) 0.82 (0.32 - 2.12)
Corticosteroids1 on a daily basis 28 (4.7) 6 (8.5) 1.89 (0.75 - 4.73)
Cytostatic treatment within last 14 days 5 (0.8) 2 (2.8) 3.46 (0.66 - 18.15)
Immunosuppressive drugs 6 (1.0) 1 (1.4) 1.42 (0.17 - 11.94)
Number of symptoms
Number of symptoms ≥ 5 69 (11.4) 8 (11.3) 0.99 (0.45 – 2.15)
“Classical symptoms”2 ≥ 3 236 (39.0) 17 (23.9) 0.49 (0.28 – 0.87)
“Atypical symptoms”3 ≥ 1 296 (48.4) 44 (61.1) 1.67 (1.02 – 2.76)
Prehospital tentative diagnosis
Infection 303 (49.6) 28 (38.9) 0.65 (0.39 – 1.07)
Non-specifica 81 (13.3) 8 (11.1) 0.82 (0.38 – 1.77)
Site of infection
Urinary tractus 241 (39.6) 14 (19.4) 0.37 (0.20 - 0.67)
Lower respiratory tractus 193 (31.7) 35 (48.6) 2.03 (1.24 - 3.33)
Othersb 95 (15.6%) 12 (16.7%) 1.08 (0.56 – 2.08)
Inconclusive 79 (13.0) 11 (15.3) 1.21 (0.61 - 2.39)
Local immunocompromizing condition
(at site of infection)
Significant anatomical or physiological abnormality 206 (38.9) 17 (27.9) 0.61 (0.34 - 1.09)
Surgical procedure performed within
14 days prior to admittance
54 (8.9) 1 (1.4) 0.15 (0.02 - 1.11)
Signs of infection in the emergency department
Fever (≥ 38.5°C) 402 (67.2) 36 (52.9) 0.55 (0.33 - 0.91) 0.46 (0.24 - 0.89)
Hypothermia (< 36 ° C) 7 (1.2) 3 (4.2) 3.90 (0.98 – 15.44)
Tachycardia 383 (63.6) 44 (63.8) 1.01 (0.60 – 1.69)
Tachypnoe and/or hyperventilation 215 (35.3) 40 (55.6) 2.29 (1.40 - 3.75)
Leukocytosis (≥ 15000/μl) 255 (41.9) 25 (35.2) 0.75 (0.45 – 1.26)
Leukopenia (< 3000/μl) 21 (3.5) 16 (22.5) 8.13 (4.01 - 16.49) 4.62 (1.88 - 11.37)
CRP ≥ 80 mg/L 457 (75.2) 57 (79.2) 1.26 (0.69 – 2.28)
CRP ≥ 200 mg/L 280 (46.1) 44 (61.1) 1.84 (1.12 – 3.04)
Decline in general health 244 (40.2) 45 (62.5) 2.48 (1.50 - 4.10)
New-onset atrial fibrillation 84 (14.0) 20 (28.2) 2.41 (1.37 - 4.25)
Number of failing organs within one
day after admission
- - 3.25 (2.48 - 4.26) 3.06 (2.2 - 4.27)
OR = odds ratio, CI = confidence interval. 1Equivalent to prednisolone ≥ 10 mg per day 2“Classical symptoms”: fever/chills, localized pain, nausea/vomiting, diarrhea,
cough, dyspnea, expectoration, urgency, painful voiding, hematuria; skin rash and coma/seizures, 3“Atypical symptoms”: Malaise, falls, dizziness, syncope,
unsteadiness, immobility, acute urinary or fecal incontinence, paresis/speaking difficulties, acute confusional state aincluding delirium and acute deterioration in
the ability to perform daily tasks bgastrointestinal tract, liver, pancreas and biliary tract.
*Interaction analyses indicated that high age significantly increased the effect of type of bacterium on hospital mortality (results not shown).
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Figure 2 Survival plots. Kaplan-Meier survival estimates for one-year survival in days, by a) age group, b) number of organ failures; 3 = failure of
three or more organs, and c) microbial agent.
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presentation hampering the diagnostic work-up and the
timeliness of treatment, rather than age being considered
a risk factor in itself. Early diagnosis of sepsis is a pre-
requisite for early goal directed therapy, which improves
outcome [30]. Decline in functional status, together with
fever, defined by lower cut-off values than those used
in SIRS and SAPS [15,16], are important criteria for
suspecting infection in older patients [31]. Decline in
functional status includes new or increasing confusion,
incontinence, falling, deteriorating mobility, reduced
food intake, or failure to cooperate with staff, which
partly corresponds to “atypical symptoms” assessed in
our study. It might constitute a problem that such “soft
variables” are not included in mortality-prediction rules for
elderly ED patients with infection [32]. Our study indicates
that such clinical presentations may be associated with
severity of infection, though not statistically significant
in the multivariate full model.
A subtle presentation may complicate the diagnosis of
infections in elderly patients [33]. In our material, clinical
judgment on general health in the ED independently pre-
dicted organ failure. The International Sepsis Definition
Conference in 2001 acknowledged the value of clinical
judgment: “Few, if any, patients in the early stages of the
inflammatory response to infection are diagnosed with
sepsis via four arbitrary criteria. Instead the clinician
goes to the bedside, identifies a myriad of symptoms and
regardless of an evident infection declares the patient to
“look septic” [21]. The updated Surviving Sepsis Campaign
guidelines acknowledge clinical judgment even stronger:
“Recommendations from these guidelines cannot replace
the clinician’s decision-making capability when he or she is
provided with at patients’ unique set of clinical variables”.
However, studies on the effectiveness of clinical judgment
in predicting prognosis are scarce. Several studies on severe
infection and sepsis did not include “soft” variables, and
instead focused on biomarkers and score systems.
Traditionally, prognostication in critical illness has relied
heavily upon measures of acute physiological derangements
upon admission to ICU, as scoring systems do not integrate
pre-hospital functional status, severity of comorbid illness,
disability or frailty [34]. Cancer, diabetes or cardiovascular
disease are the most important factors for health-related
quality of life after critical illness [35]. Comorbidity, quanti-
fied by the Charlson comorbidity index, is a prognostic
factor for in-hospital mortality [36]. In our study, the
number of comorbid illnesses and comorbidity dichoto-
mized at ≥ 1 illness were independently associated to early
organ failure and in-hospital mortality, respectively.
The main strength of the study was that patients were
recruited non-selectively and from a mixed group of
hospital patients. All patients who were admitted to the
hospital over more than a decade were included in the
study population. A major weakness is that data were
retrospectively collected. Thus, systematic information
on adequacy of antimicrobial treatment was missing and
was therefore omitted from the analyses. Furthermore,
the validity of the estimated number of failing organs
may be uncertain. We may have overestimated organ
failure because we did not exclude failure in the organ that
was considered primary source for infection. Conversely,
organ failure may also have been underestimated because
data on liver function and hematological markers as well
as markers of peripheral perfusion were unsystematically
registered and therefore excluded. The survival curve by
number of failing organs (the middle part of Figure 2),
however, is very similar to 1-year survival curves found by
others [37]. We identified leukopenia as a risk factor for
poor prognosis in the multivariate models, which corre-
sponds well with neutropenia being one of the clinical risk
factors for mortality in sepsis found in several trials [38].
We believe these findings support the importance of the
“geriatric-focused results” found in our study.
Conclusions
Elderly patients with bacteremia more often present with
atypical symptoms and reduced general condition. SIRS
have poorer sensitivity for identifying severe infection in
these patients, and should be less emphasized when
assessing the risk of sepsis in elderly patients. Advanced
age and comorbidity are risk factors for both early organ
failure and in-hospital mortality. An uncertain clinical
presentation, however, does not seem associated with in-
hospital mortality. Irrespective of age, simple observations
such as the subjective judgment of decline in general
health, as well as single aspects of SIRS such as tachypnea,
hyperventilation and leukopenia, alongside with indicators
of organ failure, are crucial when evaluating patients with
possible severe infection. Because the clinical presentation
is often atypical in advanced age, these clinical evaluations
may be seen as keys to safer care for elderly patients with
severe infection.
Key messages
 high age and comorbidity are risk factors for poor
outcome in severe infection.
 reduced general health at admittance is
underestimated as a prognostic tool.
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